Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1462088
PUBLISHER: KBV Research | PRODUCT CODE: 1462088
Europe Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Microbiome Diagnostics Market would witness market growth of 17.0% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24,425.8 Thousands by 2030. The UK market is showcasing a CAGR of 16% during (2023 - 2030). Additionally, The France market would register a CAGR of 17.9% during (2023 - 2030).
It is crucial in understanding the link between the gut microbiome and metabolic disorders such as obesity, type 2 diabetes, and metabolic syndrome. Research has shown that gut microbiota composition and function alterations can influence host metabolism, energy balance, and insulin sensitivity. It can identify microbial biomarkers associated with metabolic dysfunction, providing insights into disease mechanisms and potential therapeutic targets.
Likewise, the microbiome plays a central role in modulating immune function and responses. It studies how the gut microbiome interacts with the immune system and influences immune-mediated diseases such as allergies, autoimmune disorders, and inflammatory conditions. By profiling the microbiome-immune axis, it can identify microbial signatures associated with immune dysregulation and inflammatory diseases, informing therapeutic interventions and immune-modulating strategies. Also, the skin microbiome has emerged as a key player in maintaining skin health and integrity. It is utilized to study the composition and diversity of microbial communities on the skin and their role in dermatological conditions such as acne, eczema, psoriasis, and wound healing. Understanding the skin microbiome's dynamics and its interaction with the host can inform personalized skincare interventions and therapeutic approaches for various dermatological ailments.
In addition, the high prevalence of respiratory diseases in Europe drives demand for microbiome diagnostics in research and clinical settings. According to Eurostat, respiratory illnesses accounted for 347 867 deaths in the EU in 2020 or 6.7% of all fatalities among citizens. In 2020, the proportion of deaths from respiratory diseases in Malta, Denmark, and Ireland was considerably higher than the EU average, at 10.5 %, 10.4 %, and 10.0 %, respectively. As research continues to unravel the complex interplay between the respiratory microbiome and respiratory health, it will play an increasingly critical role in shaping the future of respiratory medicine in Europe and beyond. Thus, the high prevalence of respiratory diseases and the expansion of the pharmaceutical industry in the region is propelling the market's growth.
Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Illumina, Inc.
- Becton, Dickinson and Company
- Genetic Analysis AS
- Microba Life Sciences Limited
- BioMe Oxford Ltd
- Viome Life Sciences, Inc.
- GoodGut S.L.U. (HIPRA, S.A.)
- Sun Genomics
- Origin Sciences Limited
- Decode Age
Europe Microbiome Diagnostics Market Report Segmentation
By Application
- Disease Diagnostics
- Gastrointestinal Disorders
- Metabolic Diseases
- Others
- Research Application
By Product
- Reagents & Kits
- Instruments
By Sample
- Fecal
- Saliva
- Skin
- Others
By Technology
- 16S rRNA Sequencing
- Shot Gun Metagenomics
- Metatranscriptomics
- Others
By End User
- Hospitals
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Europe Microbiome Diagnostics Market, by Application
- 1.4.2Europe Microbiome Diagnostics Market, by Product
- 1.4.3Europe Microbiome Diagnostics Market, by Sample
- 1.4.4Europe Microbiome Diagnostics Market, by Technology
- 1.4.5Europe Microbiome Diagnostics Market, by End User
- 1.4.6Europe Microbiome Diagnostics Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter Five Forces Analysis
Chapter 4.Strategies Deployed in Microbiome Diagnostics Market
Chapter 5.Europe Microbiome Diagnostics Market by Application
- 5.1Europe Disease Diagnostics Market by Country
- 5.2Europe Microbiome Diagnostics Market by Disease Diagnostics Type
- 5.2.1Europe Gastrointestinal Disorders Market by Country
- 5.2.2Europe Metabolic Diseases Market by Country
- 5.2.3Europe Others Market by Country
- 5.3Europe Research Application Market by Country
Chapter 6.Europe Microbiome Diagnostics Market by Product
- 6.1Europe Reagents & Kits Market by Country
- 6.2Europe Instruments Market by Country
Chapter 7.Europe Microbiome Diagnostics Market by Sample
- 7.1Europe Fecal Market by Country
- 7.2Europe Saliva Market by Country
- 7.3Europe Skin Market by Country
- 7.4Europe Others Market by Country
Chapter 8.Europe Microbiome Diagnostics Market by Technology
- 8.1Europe 16S rRNA Sequencing Market by Country
- 8.2Europe Shot Gun Metagenomics Market by Country
- 8.3Europe Metatranscriptomics Market by Country
- 8.4Europe Others Market by Country
Chapter 9.Europe Microbiome Diagnostics Market by End User
- 9.1Europe Hospitals Market by Country
- 9.2Europe Academic & Research Institutes Market by Country
- 9.3Europe Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10.Europe Microbiome Diagnostics Market by Country
- 10.1Germany Microbiome Diagnostics Market
- 10.1.1Germany Microbiome Diagnostics Market by Application
- 10.1.1.1Germany Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.1.2Germany Microbiome Diagnostics Market by Product
- 10.1.3Germany Microbiome Diagnostics Market by Sample
- 10.1.4Germany Microbiome Diagnostics Market by Technology
- 10.1.5Germany Microbiome Diagnostics Market by End User
- 10.1.1Germany Microbiome Diagnostics Market by Application
- 10.2UK Microbiome Diagnostics Market
- 10.2.1UK Microbiome Diagnostics Market by Application
- 10.2.1.1UK Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.2.2UK Microbiome Diagnostics Market by Product
- 10.2.3UK Microbiome Diagnostics Market by Sample
- 10.2.4UK Microbiome Diagnostics Market by Technology
- 10.2.5UK Microbiome Diagnostics Market by End User
- 10.2.1UK Microbiome Diagnostics Market by Application
- 10.3France Microbiome Diagnostics Market
- 10.3.1France Microbiome Diagnostics Market by Application
- 10.3.1.1France Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.3.2France Microbiome Diagnostics Market by Product
- 10.3.3France Microbiome Diagnostics Market by Sample
- 10.3.4France Microbiome Diagnostics Market by Technology
- 10.3.5France Microbiome Diagnostics Market by End User
- 10.3.1France Microbiome Diagnostics Market by Application
- 10.4Russia Microbiome Diagnostics Market
- 10.4.1Russia Microbiome Diagnostics Market by Application
- 10.4.1.1Russia Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.4.2Russia Microbiome Diagnostics Market by Product
- 10.4.3Russia Microbiome Diagnostics Market by Sample
- 10.4.4Russia Microbiome Diagnostics Market by Technology
- 10.4.5Russia Microbiome Diagnostics Market by End User
- 10.4.1Russia Microbiome Diagnostics Market by Application
- 10.5Spain Microbiome Diagnostics Market
- 10.5.1Spain Microbiome Diagnostics Market by Application
- 10.5.1.1Spain Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.5.2Spain Microbiome Diagnostics Market by Product
- 10.5.3Spain Microbiome Diagnostics Market by Sample
- 10.5.4Spain Microbiome Diagnostics Market by Technology
- 10.5.5Spain Microbiome Diagnostics Market by End User
- 10.5.1Spain Microbiome Diagnostics Market by Application
- 10.6Italy Microbiome Diagnostics Market
- 10.6.1Italy Microbiome Diagnostics Market by Application
- 10.6.1.1Italy Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.6.2Italy Microbiome Diagnostics Market by Product
- 10.6.3Italy Microbiome Diagnostics Market by Sample
- 10.6.4Italy Microbiome Diagnostics Market by Technology
- 10.6.5Italy Microbiome Diagnostics Market by End User
- 10.6.1Italy Microbiome Diagnostics Market by Application
- 10.7Rest of Europe Microbiome Diagnostics Market
- 10.7.1Rest of Europe Microbiome Diagnostics Market by Application
- 10.7.1.1Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type
- 10.7.2Rest of Europe Microbiome Diagnostics Market by Product
- 10.7.3Rest of Europe Microbiome Diagnostics Market by Sample
- 10.7.4Rest of Europe Microbiome Diagnostics Market by Technology
- 10.7.5Rest of Europe Microbiome Diagnostics Market by End User
- 10.7.1Rest of Europe Microbiome Diagnostics Market by Application
Chapter 11.Company Profiles
- 11.1Illumina, Inc.
- 11.1.1Company Overview
- 11.1.2Financial Analysis
- 11.1.3Regional Analysis
- 11.1.4Research & Development Expense
- 11.1.5Recent strategies and developments:
- 11.1.5.1Partnerships, Collaborations, and Agreements:
- 11.1.6SWOT Analysis
- 11.2Becton, Dickinson, and Company
- 11.2.1Company Overview
- 11.2.2Financial Analysis
- 11.2.3Segmental and Regional Analysis
- 11.2.4Research & Development Expense
- 11.2.5Recent strategies and developments:
- 11.2.5.1Product Launches and Product Expansions:
- 11.2.5.2Trails and Approvals:
- 11.2.6SWOT Analysis
- 11.3Genetic Analysis AS
- 11.3.1Company Overview
- 11.3.2Financial Analysis
- 11.3.3Regional Analysis
- 11.3.4Recent strategies and developments:
- 11.3.4.1Partnerships, Collaborations, and Agreements:
- 11.4Microba Life Sciences Limited
- 11.4.1Company Overview
- 11.4.2Financial Analysis
- 11.4.3Regional Analysis
- 11.4.4Research & Development Expenses
- 11.4.5Recent strategies and developments:
- 11.4.5.1Partnerships, Collaborations, and Agreements:
- 11.4.5.2Product Launches and Product Expansions:
- 11.5BioMe Oxford Ltd
- 11.5.1Company Overview
- 11.5.2Recent strategies and developments:
- 11.5.2.1Partnerships, Collaborations, and Agreements:
- 11.6Viome Life Sciences, Inc.
- 11.6.1Company Overview
- 11.6.2Recent strategies and developments:
- 11.6.2.1Product Launches and Product Expansions:
- 11.6.2.2Acquisition and Mergers:
- 11.7GoodGut S.L.U. (HIPRA, S.A.)
- 11.7.1Company Overview
- 11.8Sun Genomics
- 11.8.1Company Overview
- 11.9Origin Sciences Limited
- 11.9.1Company Overview
- 11.10.Decode Age
- 11.10.1Company Overview
LIST OF TABLES
- TABLE 1Europe Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 2Europe Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 3Europe Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 4Europe Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 5Europe Disease Diagnostics Market by Country, 2019 - 2022, USD Thousands
- TABLE 6Europe Disease Diagnostics Market by Country, 2023 - 2030, USD Thousands
- TABLE 7Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 8Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 9Europe Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
- TABLE 10Europe Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
- TABLE 11Europe Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
- TABLE 12Europe Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
- TABLE 13Europe Others Market by Country, 2019 - 2022, USD Thousands
- TABLE 14Europe Others Market by Country, 2023 - 2030, USD Thousands
- TABLE 15Europe Research Application Market by Country, 2019 - 2022, USD Thousands
- TABLE 16Europe Research Application Market by Country, 2023 - 2030, USD Thousands
- TABLE 17Europe Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 18Europe Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 19Europe Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
- TABLE 20Europe Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
- TABLE 21Europe Instruments Market by Country, 2019 - 2022, USD Thousands
- TABLE 22Europe Instruments Market by Country, 2023 - 2030, USD Thousands
- TABLE 23Europe Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 24Europe Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 25Europe Fecal Market by Country, 2019 - 2022, USD Thousands
- TABLE 26Europe Fecal Market by Country, 2023 - 2030, USD Thousands
- TABLE 27Europe Saliva Market by Country, 2019 - 2022, USD Thousands
- TABLE 28Europe Saliva Market by Country, 2023 - 2030, USD Thousands
- TABLE 29Europe Skin Market by Country, 2019 - 2022, USD Thousands
- TABLE 30Europe Skin Market by Country, 2023 - 2030, USD Thousands
- TABLE 31Europe Others Market by Country, 2019 - 2022, USD Thousands
- TABLE 32Europe Others Market by Country, 2023 - 2030, USD Thousands
- TABLE 33Europe Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 34Europe Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 35Europe 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
- TABLE 36Europe 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
- TABLE 37Europe Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
- TABLE 38Europe Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
- TABLE 39Europe Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
- TABLE 40Europe Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
- TABLE 41Europe Others Market by Country, 2019 - 2022, USD Thousands
- TABLE 42Europe Others Market by Country, 2023 - 2030, USD Thousands
- TABLE 43Europe Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 44Europe Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 45Europe Hospitals Market by Country, 2019 - 2022, USD Thousands
- TABLE 46Europe Hospitals Market by Country, 2023 - 2030, USD Thousands
- TABLE 47Europe Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
- TABLE 48Europe Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
- TABLE 49Europe Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
- TABLE 50Europe Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
- TABLE 51Europe Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
- TABLE 52Europe Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
- TABLE 53Germany Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 54Germany Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 55Germany Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 56Germany Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 57Germany Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 58Germany Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 59Germany Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 60Germany Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 61Germany Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 62Germany Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 63Germany Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 64Germany Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 65Germany Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 66Germany Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 67UK Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 68UK Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 69UK Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 70UK Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 71UK Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 72UK Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 73UK Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 74UK Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 75UK Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 76UK Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 77UK Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 78UK Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 79UK Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 80UK Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 81France Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 82France Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 83France Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 84France Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 85France Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 86France Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 87France Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 88France Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 89France Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 90France Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 91France Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 92France Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 93France Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 94France Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 95Russia Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 96Russia Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 97Russia Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 98Russia Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 99Russia Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 100Russia Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 101Russia Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 102Russia Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 103Russia Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 104Russia Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 105Russia Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 106Russia Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 107Russia Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 108Russia Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 109Spain Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 110Spain Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 111Spain Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 112Spain Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 113Spain Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 114Spain Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 115Spain Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 116Spain Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 117Spain Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 118Spain Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 119Spain Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 120Spain Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 121Spain Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 122Spain Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 123Italy Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 124Italy Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 125Italy Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 126Italy Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 127Italy Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 128Italy Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 129Italy Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 130Italy Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 131Italy Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 132Italy Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 133Italy Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 134Italy Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 135Italy Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 136Italy Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 137Rest of Europe Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
- TABLE 138Rest of Europe Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
- TABLE 139Rest of Europe Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
- TABLE 140Rest of Europe Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
- TABLE 141Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
- TABLE 142Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
- TABLE 143Rest of Europe Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
- TABLE 144Rest of Europe Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
- TABLE 145Rest of Europe Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
- TABLE 146Rest of Europe Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
- TABLE 147Rest of Europe Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
- TABLE 148Rest of Europe Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
- TABLE 149Rest of Europe Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
- TABLE 150Rest of Europe Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
- TABLE 151key information - Illumina, Inc.
- TABLE 152Key Information - Becton, Dickinson and Company
- TABLE 153Key Information - Genetic Analysis AS
- TABLE 154Key Information - Microba Life Sciences Limited
- TABLE 155Key Information -BioMe Oxford Ltd
- TABLE 156Key Information - Viome Life Sciences, Inc.
- TABLE 157Key Information - GoodGut S.L.U.
- TABLE 158Key Information - Sun Genomics
- TABLE 159Key Information - Origin Sciences Limited
- TABLE 160Key Information - Decode Age
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.